Zukünftige P/E von NUGL, Inc. ist N/A
Das Terminkurs-Gewinn-Verhältnis ist das Verhältnis des Aktienkurses eines Unternehmens zum geschätzten Gewinn des Unternehmens für die nächsten zwölf Monate.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America. The company was founded in 2018 and is based in Kingston, Jamaica.